scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1002905114 |
P356 | DOI | 10.1186/1475-2875-13-487 |
P932 | PMC publication ID | 4295290 |
P698 | PubMed publication ID | 25495520 |
P5875 | ResearchGate publication ID | 269720734 |
P50 | author | Frances C Recuenco | Q84391543 |
P2093 | author name string | Taisuke Horimoto | |
Ryo Takano | |||
Kentaro Kato | |||
Hitoshi Takemae | |||
Tatsuki Sugi | |||
Fumi Murakoshi | |||
Noriyuki Horiuchi | |||
Yoshiyasu Kobayashi | |||
Akiko Ishiwa | |||
Atsuko Inomata | |||
Shiori Chiba | |||
P2860 | cites work | Cerebral malaria: mysteries at the blood-brain barrier | Q21032533 |
A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria | Q27318676 | ||
Neuroimmunological blood brain barrier opening in experimental cerebral malaria | Q27341951 | ||
Sulfated polyanions inhibit invasion of erythrocytes by plasmodial merozoites and cytoadherence of endothelial cells to parasitized erythrocytes | Q35483364 | ||
Cytokine profile suggesting that murine cerebral malaria is an encephalitis | Q35559322 | ||
Sequestration and microvascular congestion are associated with coma in human cerebral malaria | Q35694762 | ||
A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. | Q36595999 | ||
Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9. | Q37359865 | ||
Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain | Q37561363 | ||
Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury | Q37703098 | ||
Gellan sulfate inhibits Plasmodium falciparum growth and invasion of red blood cells in vitro. | Q37707381 | ||
The pathology of human cerebral malaria | Q37948795 | ||
Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36. | Q40398384 | ||
Breaking free of sample size dogma to perform innovative translational research | Q42117164 | ||
Consumption of carrageenan and other water-soluble polymers used as food additives and incidence of mammary carcinoma | Q43627527 | ||
Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. | Q44138424 | ||
Suppression of allergic reaction by lambda-carrageenan: toll-like receptor 4/MyD88-dependent and -independent modulation of immunity | Q44311506 | ||
Extremely small sample size in some toxicity studies: an example from the rabbit eye irritation test | Q47211247 | ||
Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. | Q47842059 | ||
Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice | Q47848359 | ||
Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner | Q47980772 | ||
Plasmodium berghei: effect of carrageenan on the course of infection of the A/J mouse | Q47991753 | ||
Saccharide anions as inhibitors of the malaria parasite | Q48037140 | ||
Carrageenan-induced intestinal injury in the rat--a model for inflammatory bowel disease | Q70235514 | ||
Anaphylaxis to carrageenan: a pseudo-latex allergy | Q72239852 | ||
P921 | main subject | malaria | Q12156 |
cerebral malaria | Q2822915 | ||
Plasmodium berghei | Q65021 | ||
P304 | page(s) | 487 | |
P577 | publication date | 2014-12-11 | |
P1433 | published in | Malaria Journal | Q15749954 |
P1476 | title | Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice | |
P478 | volume | 13 |
Q48005441 | Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development | cites work | P2860 |
Search more.